AP3D1

AP3D1 encodes the δ subunit of the AP-3 adaptor protein complex and is essential for assembly and stability of both the ubiquitous and neuronal forms of AP-3, which direct vesicle-mediated trafficking of cargo to late endosomal and lysosomal compartments (PMID:26744459). Through its δ subunit, AP3D1 selects specific cargo for lysosomal delivery: it binds S-palmitoylated IFNGR1 (Cys122) to route the receptor for lysosomal degradation (PMID:33627378), and it captures DRAM2 in a phosphorylation-dependent manner, requiring RSK2-mediated phosphorylation at Ser263, such that the non-phosphorylatable DRAM2(S263A) loses AP3D1 binding and is instead diverted to the plasma membrane to enhance exosome secretion (PMID:42059423). AP3D1 also participates in TGFβ2 secretion via an AP-3-dependent late endosomal/exosomal route (PMID:34166600) and governs the endolysosomal trafficking and lysosomal localization of cargo such as RNF13 (PMID:34831286). Consistent with its role in lysosome-related organelle biogenesis, loss-of-function mutations in AP3D1 destabilize the complex and cause a Hermansky-Pudlak-type disorder featuring immunodeficiency with defective T-cell degranulation (PMID:26744459) and abnormal platelet dense granule storage (PMID:30472485). In the nervous system, AP3D1 loss perturbs neurotransmitter vesicle turnover and synaptic transmission and is required for proper retinal progenitor differentiation (PMID:19032734, PMID:19631730).

1. 2009 Medium

   Establishing the in vivo consequence of Ap3d1 loss showed that the δ subunit is required for vesicle transport supporting neurotransmitter turnover and for retinal neuron differentiation, linking AP-3 to neuronal phenotypes.

   Evidence Genomic mapping of the mocha deletion with patch-clamp electrophysiology and retinal immunohistochemistry in Ap3d1-null mice

   PMID:19032734 PMID:19631730

   Open questions at the time

   • Specific synaptic vesicle cargo mistrafficked is not identified
   • Molecular basis of amacrine cell competence defect unknown
2. 2009 Medium

   A genetic suppressor study demonstrated that restoring Ap3d1 expression above a functional threshold via altered pre-mRNA splicing rescues the mutant phenotype, defining Ap3d1 dosage sensitivity.

   Evidence Genetic epistasis with the Nxf1(CAST) allele and quantitative RT-PCR of splice isoforms in mocha mice

   PMID:19436707

   Open questions at the time

   • Mechanism by which Nxf1 modulates Ap3d1 splicing not resolved
   • Threshold quantification specific to one mutant allele
3. 2016 High

   Patient genetics established AP3D1 as a disease gene whose loss destabilizes the entire AP-3 complex, with reconstitution rescuing the T-cell degranulation defect, proving AP3D1 is essential for complex assembly and immune lysosome-related organelle function.

   Evidence Whole exome sequencing, retroviral reconstitution with functional degranulation rescue in patient T cells

   PMID:26744459

   Open questions at the time

   • Full spectrum of mistrafficked immune cargo not enumerated
   • Neurological component of the syndrome not mechanistically dissected
4. 2018 Medium

   An independent loss-of-function family confirmed AP3D1 is required for lysosome-related organelle biogenesis by demonstrating an abnormal platelet dense granule storage pathway.

   Evidence Whole exome sequencing and platelet storage pathway analysis

   PMID:30472485

   Open questions at the time

   • Cargo defects underlying granule deficiency not identified
   • Single family
5. 2018 Low

   An in vitro and in silico study raised AP3D1 as a candidate binding partner for BLV envelope gp51, but without biochemical validation of the implicated residues.

   Evidence Recombinant peptide binding assay, homology modeling/docking, and protease-sensitivity cell binding with bovine AP3D1

   PMID:29928016

   Open questions at the time

   • Predicted interaction residues not biochemically validated
   • Functional relevance to viral entry untested
   • Bovine ortholog only
6. 2021 High

   Identification of palmitoylated IFNGR1 as an AP3D1 cargo revealed how AP-3 controls receptor surface levels and immune signaling, and showed optineurin antagonizes this sorting.

   Evidence Reciprocal co-IP, palmitoylation mapping (Cys122), lysosomal sorting and rescue assays with optineurin knockout

   PMID:33627378

   Open questions at the time

   • Structural basis of palmitoyl-cargo recognition by the δ subunit unknown
   • Generality across other palmitoylated receptors untested
7. 2021 Medium

   AP3D1 was shown to scaffold a secretory route, forming a complex with FAM13A and TGFβ2 to direct TGFβ2 to late endosomes for exosomal secretion, expanding AP-3 function beyond degradation.

   Evidence Co-immunoprecipitation of the ternary complex and functional secretion assay

   PMID:34166600

   Open questions at the time

   • Direct vs indirect contacts within the ternary complex not resolved
   • Single lab
8. 2021 Medium

   Knockdown placed AP3D1 upstream of RNF13 endolysosomal trafficking, reinforcing its broad role in cargo delivery to lysosomes and endosomal morphology.

   Evidence siRNA knockdown with LAMP1 co-localization microscopy and endosomal vesicle size measurement

   PMID:34831286

   Open questions at the time

   • Direct AP3D1-RNF13 binding not demonstrated
   • Single lab
9. 2022 Medium

   Zebrafish ortholog loss linked ap3d1 to melanophore survival by limiting excessive autophagy and supporting melanogenesis gene expression, connecting AP-3 to pigment cell biology.

   Evidence ENU mutant and CRISPR knockout zebrafish, RT-qPCR, pathway analysis, and bafilomycin A1 rescue with melanophore counting

   PMID:35816398

   Open questions at the time

   • Cargo mediating autophagy restraint not identified
   • Mammalian relevance of the autophagy link not established here
10. 2026 High

    Demonstrating phosphorylation-gated cargo selection, RSK2 phosphorylation of DRAM2 at Ser263 was shown to license AP3D1 binding and lysosomal trafficking, with loss of phosphorylation rerouting cargo to plasma-membrane-driven exosome secretion.

    Evidence Co-IP with S263A mutagenesis, lysosomal trafficking and exosome secretion assays in melanoma models

    PMID:42059423

    Open questions at the time

    • Whether δ subunit directly reads the phosphosite or via another AP-3 surface unclear
    • Generality of phospho-dependent cargo sorting by AP-3 unknown

• How AP3D1 discriminates among its diverse cargo (palmitoylated, phosphorylated, and secretory) and the structural basis of recognition by the δ subunit remain unresolved.
• No structural model of δ-subunit cargo recognition
• Determinants routing cargo to degradation vs exosomal secretion not defined